Location: Home
  • search
  • go
  • Relate News
  • 4/8/2015Recent Executive Movements
  • 4/8/2015GSK to Take Over China Vaccine Business from Novartis Following Global...
  • 4/8/2015Hospital Oncology Drug Consumption of Six Cities in Yangtze River Vici...
  • 4/8/2015Review of Drug Consumption in Chinese County Level Hospitals
  • 4/8/2015Financial-related Company News in Brief
  • 4/8/2015Resverlogix Receives Two Chinese Patents for Its BET Inhibitor
  • 4/7/2015Global Strategic Partners Merck and Pfizer Finalize Agreement to Co-Pr...
  • 4/7/2015Upcoming Event: Asia Healthcare Summit
  • 4/7/2015Upcoming Event: ISPE
  • 4/7/2015Upcoming Event: Biopharma Development & Production
  • 4/6/2015Medidata Expands Partnership with PKU for Clinical Cloud-Based Technol...
  • 4/6/2015MOHRSS Issues Adjustment Notice of the 2009 NDRL
  • 4/3/2015Wuxi PharmaTech's CMO Subsidiary STA Approved for IPO in China
  • 4/3/2015J&J CEO Pledges Long Term Commitment to China
  • 4/3/2015Merck Expects Continued Double-digit Growth in China
  • 4/3/2015Uremia Patients in Chongqing Protest Against Latest Healthcare Reform ...
  • 4/3/2015Overweight and Obesity A Fast Rising Problem Among Younger Chinese Are
  • 4/3/2015Covance and Sihuan Announce Partnership for Global Pipeline Developmen...
  • 4/3/2015Pfizer to Suspend China Vaccine Business After CFDA's Import Renewal R...
  • 4/3/2015Birth of A New Novel Anticancer, Made in China
  • 4/1/2015New Report: Chinese Human Vaccine Output Down 2.4% in 2014
  • 4/1/2015Upcoming Event: 7th DIA China Annual Meeting
  • 4/1/2015CFDA Vice Minister YIN Li Transferred to Sichuan
  • 4/1/2015CDE Solicits Feedbacks on Bioavailability and Bioequivalence Guideline
  • 4/1/2015Local Governments Catches the NHFPC Momentum to Contain Drug Costs
  • 4/1/2015State Council Issues Plan Document for National Healthcare Service Inf...
  • 4/1/2015CFDA Approves CASI's Phase II Trial for ENMD-2076 To Treat OCCC
  • 3/31/2015Neurocrine, Mitsubishi Tanabe Reach Asian Licensing Agreement for Neur...
  • 3/31/2015BMS Licenses China Rights of HCC Drug to Zai Lab
  • 3/31/2015DKSH Licenses Two Pharma Brands to China Medical Systems
  • Page:457/790 Total number of articles:23678: [First][<<] [455] [456] [457] [458] [459] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group